semaglutide for diabetes wichita A new study is raising concerns about GLP-1 weight loss drugs and eating disorders. Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least FDA Warns on Certain Forms

If GI symptoms are still significant at the end of a four-week block, the documented approach is to hold the current dose longer rather than escalate on schedule

Attenuation of High Glucose-Induced Rat Cardiomyocyte Apoptosis by Exendin-4 via Intervention of HO-1/Nrf-2 and the PI3K/AKT Signaling Pathway

A Deep Dive into the Science of Satiety and Metabolism This video from Harvard Medical School is a good research-backed overview of GLP-1 medications and how they work

A Review of Efficacy Studies of 6-Month Short-Course Therapy for Tuberculosis Among Patients Infected With Human Immunodeficiency Virus: Differences in Study Outcomes

Pharmaceutical companies are channeling significant resources into improving peptide stability, exploring oral formulations, and creating multi-agonist drugs that enhance treatment outcomes

At Blue Fin Vision, our consultant-led team can provide urgent evaluation of the optic nerve and wider visual system and can advise you and your prescribing doctor on next steps